Pharma companies use TPP to extend their monopolies (Video)

Monday, March 21, 2016 by

Brand-name prescription drug prices have doubled in the last five years, according to a new report. Now some public health groups and organizations say things could get worse, if the Trans-Pacific Partnership deal delays the introduction of generic drugs. RT America’s Ed Schultz speaks with Lori Wallach, director of Public Citizen’s Global Trade Watch, about how the new deal could lead to even higher costs of medication.


Comments

comments powered by Disqus

×
Please like our Facebook Page
Show us your support by liking our page!
Close This Box